rdf:type |
|
lifeskim:mentions |
umls-concept:C0006141,
umls-concept:C0013840,
umls-concept:C0018418,
umls-concept:C0021149,
umls-concept:C0178602,
umls-concept:C0205171,
umls-concept:C0355642,
umls-concept:C0392756,
umls-concept:C0445202,
umls-concept:C0677582,
umls-concept:C1522449
|
pubmed:issue |
2
|
pubmed:dateCreated |
2004-9-21
|
pubmed:abstractText |
To evaluate the efficacy and tolerability of prophylactic breast irradiation in reducing the incidence and severity of bicalutamide-induced gynecomastia and breast pain.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0360-3016
|
pubmed:author |
pubmed-author:AnderssonSwen-OlofSO,
pubmed-author:BakkeAugustA,
pubmed-author:BoonTomT,
pubmed-author:CarrollKevinK,
pubmed-author:GoedhalsLouisL,
pubmed-author:LoddingPärP,
pubmed-author:MorrisTomT,
pubmed-author:PayneHeatherH,
pubmed-author:TammelaTeuvo L JTL,
pubmed-author:TyrrellChristopher JCJ,
pubmed-author:Van De BeekCeesC,
pubmed-author:Van ErpsPeterP
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
60
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
476-83
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15380582-Aged,
pubmed-meshheading:15380582-Aged, 80 and over,
pubmed-meshheading:15380582-Androgen Antagonists,
pubmed-meshheading:15380582-Anilides,
pubmed-meshheading:15380582-Breast,
pubmed-meshheading:15380582-Breast Diseases,
pubmed-meshheading:15380582-Confidence Intervals,
pubmed-meshheading:15380582-Double-Blind Method,
pubmed-meshheading:15380582-Electrons,
pubmed-meshheading:15380582-Gynecomastia,
pubmed-meshheading:15380582-Humans,
pubmed-meshheading:15380582-Male,
pubmed-meshheading:15380582-Middle Aged,
pubmed-meshheading:15380582-Nitriles,
pubmed-meshheading:15380582-Pain,
pubmed-meshheading:15380582-Prostatic Neoplasms,
pubmed-meshheading:15380582-Tosyl Compounds
|
pubmed:year |
2004
|
pubmed:articleTitle |
Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia.
|
pubmed:affiliation |
Oncology Research Unit, Plymouth Oncology Centre, Plymouth, United Kingdom.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|